Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Utilizing Near-Infrared Fluorescent Antibodies to Target EpCAM Expression for Enhanced Microscopic Visualization of Primary and Recurrent HNSCC

  • By

  • Bernd Uhl

  • Dennis Eggert

  • Bojan Smiljanov

  • Katharina von Thun und Hohenstein

  • Christoph Walz

  • Gisela Kranz

  • Sabina Schwenk-Zieger

  • Florian Haring

  • Joshua Luft

  • Jiahang Song

  • Vincent Holtmann

  • Philipp Baumeister

  • Christoph A. Reichel

  • Olivier Gires

  • Martin Canis

  • Christian Betz

  • May 25, 2026

Share

Original Source(s)

Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC

  • by Bernd Uhl, Dennis Eggert, Bojan Smiljanov, Katharina von Thun und Hohenstein, Christoph Walz, Gisela Kranz, Sabina Schwenk-Zieger, Florian Haring, Joshua Luft, Jiahang Song, Vincent Holtmann, Philipp Baumeister, Christoph A. Reichel, Olivier Gires, Martin Canis, Christian Betz

  • May 25, 2026

Related Content

Ancestry informative genetic variants associated with tobacco metabolic and detoxification capacity measured by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) among smokers

Multimodal salvage therapy for locally advanced esophageal cancer recurrence after failed post-ESD surveillance: a case report

Efficiency and Sustainability in the Skin Cancer Excision Pathway: Life Cycle Assessment and Process Map